Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 5, 1999, Pages 1534-1539

  Sabbah, Emad ^a   Savola, Kaisa ^a   Kulmala, Petri ^a   Veijola, Riitta ^a   Vähäsalo, Paula ^a   Karjalainen, Jukka ^a   Åkerblom, Hans K ^b   Knip, Mikael ^a,c  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUTAMATE DECARBOXYLASE; GLYCOSYLATED HEMOGLOBIN; INSULIN; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ARTICLE; CELL DAMAGE; CHILD; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REMISSION;

EID: 0033311156     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.5.1534     Document Type: Article

References (33)

1. Type 1 diabetes: A chronic autoimmune disease
2. Pathogenesis of insulin-dependent diabetes mellitus
3. Natural history of preclinical IDDM in high-risk siblings
4. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies
5. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
6. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma
7. Binding of antibodies in sera from type 1 (insulin-dependent) diabetic patients to glutamic acid decarboxylase from rat tissues. Evidence for antigenic and non-antigenic forms of the enzyme
8. Negative correlation between ICA persistence and beta cell restoration after IDDM diagnosis
9. Correlation between residual β-cell function and islet cell antibodies in newly diagnosed type 1 diabetes. Follow-up study
10. Insulin autoantibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes - A poor predictor of clinical course and antibody response to exogenous insulin
11. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives
12. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICAbdc/IA-2 autoantibodies
13. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes
14. Epidemiology of childhood diabetes mellitus in Finland - Background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus
15. 65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay
16. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes
17. Combined use of autoantibodies (IA-2 antibody, GAD antibody, insilin antibody, cytoplasmic islet cell antibodies) in type 1 diabetes. Combinatorial islet autoantibody workshop
18. IA-2 antibodies - A sensitive marker of IDDM with clinical onset in childhood and adolescence
19. A novel microassay for insulin autoantibodies
20. The fourth international serum exchange workshop to standardize cytoplasmic islet cell antibodies
21. Radioimmunological determination of human C-peptide in serum
22. Calculating confidence intervals for relative risks, odds ratios, and standardised ratios and rates
23. Age governs gender-dependent islet cell autoreactivity and predicts the clinical course in childhood IDDM
24. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of β-cell function and remission in recent-onset IDDM after cyclosporin treatment
25. Persistence of serum antibodies to 64,000-M(r) islet cell protein after onset of type 1 diabetes
26. Autoantibodies to 64,000-Mr islet cell protein in long-term type 1 (insulin-dependent) diabetic patients
27. Disease associated autoantibodies persist after the diagnosis of IDDM in children
28. High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symptomatic autonomic neuropathy
29. Association of IA-2 autoantibodies with HLA DR4 phenotypes on IDDM
30. Evidence of an accelerated β-cell destruction in HLA-Dw3/Dw4 heterozygous children with type 1 (insulin-dependent) diabetes
31. Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children
32. Prospective study of predictors of β-cell survival in type 1 diabetes
33. Factors influencing the magnitude, duration, and rate of fall of β-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis